1-10 of 10
Rossella Troia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, MD, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Mattia D'Agostino, MD, Rossella Ribolla, MD, Monica Galli, Manuela Racca, MD, Renato Zambello, Elena Rivolti, MD, Domenico Albano, MD, Annibale Versari, MD, Mariella Grasso, Rossella Troia, PharmD, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, MD, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, MD PhD, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137412
Published: 2020
Journal Articles

Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95)

Pieter Sonneveld, MD PhD, Meral Beksac, MD, Bronno Van Der Holt, PhD, Meletios A Dimopoulos, Angelo Michele Carella, MD, Heinz Ludwig, MD, Sonja Zweegman, MD PhD, Thilo Zander, MD, Ruth Wester, MD, Roman Hajek, MD, Lucia Pantani, MD PhD, Luca Dozza, MSc, Francesca Gay, MD, Anna Maria Cafro, Luca De Rosa, Francesca Fioritoni, MD, Ulf-Henrik Mellqvist, MD PhD, Rossella Troia, PharmD, Niels Frost Andersen, MD PhD, Ka Lung Wu, MD PhD, Christoph Driessen, MD, Susana Carvalho, MD, Alexandra J. Croockewit, MD PhD, Fredrik Schjesvold, MDPhD, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–48.
https://doi.org/10.1182/blood-2020-139337
Published: 2020
Journal Articles

Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study

Michele Cavo, Francesca Gay, MD, Meral Beksac, MD, Meletios A Dimopoulos, Lucia Pantani, MD PhD, Maria Teresa Petrucci, Luca Dozza, MSc, Bronno Van Der Holt, PhD, Sonja Zweegman, MDPhD, Elena Zamagni, Giuseppe A. Palumbo, MD PhD, Francesca Patriarca, Monica Galli, Vladimir Maisnar, MD PhD MBA, Markus Hansson, MD, Angelo Belotti, Ludek Pour, MD, Paula F Ypma, MD PhD, Mariella Grasso, Sandra Croockewit, MD, Massimo Offidani, Renato Zambello, Anna Marina Liberati, MD, Niels Frost Andersen, MD PhD, Annemiek Broyl, MD PhD, Rossella Troia, PharmD, Pellegrino Musto, Heinz Ludwig, MD, Anna Maria Morelli, MD, Roman Hajek, MD, Christoph Driessen, MD, Anders Waage, MD PhD, Peter Gimsing, DO, PhD, Ulf-Henrik Mellqvist, MD PhD, Thilo Zander, MD, Mario Boccadoro, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137575
Published: 2020
Journal Articles

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Elena Zamagni, MD, Cristina Nanni, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Paola Omedé, Rossella Ribolla, MD, Monica Galli, Manuela Racca, Renato Zambello, Barbara Gamberi, MD, Domenico Albano, Annibale Versari, Mariella Grasso, Rossella Troia, Tonino Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, Prof, MD PhD, Mario Boccadoro, Michele Cavo, Stefania Oliva
Journal: Blood
Blood (2019) 134 (Supplement_1): 4321.
https://doi.org/10.1182/blood-2019-125134
Published: 2019
Journal Articles

Bortezomib-Dexamethasone Re-Treatment at Biochemical Relapse Vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II Multi-Center, Randomized Study

Roberto Mina, MD, Alessandra Larocca, Angelo Belotti, MD, Francesco Di Raimondo, MD, Anna Baraldi, MD, Massimo Offidani, MD, Monia Marchetti, MD, Roberto Ria, MD, Annarita Conconi, MD, Norbert Pescosta, MD, Mariella Grasso, MD, Giusy Cetani, MD, Anna Maria Cafro, MD, Roberto Passera, Rossella Troia, Gianpietro Semenzato, MD, Nicola Giuliani, MD PhD, Stelvio Ballanti, MD, Claudia Cellini, MD, Anna Marina Liberati, Tommaso Caravita di Toritto, MD, Maria Teresa Petrucci, MD, Pellegrino Musto, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD, Mario Boccadoro, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3128.
https://doi.org/10.1182/blood.V130.Suppl_1.3128.3128
Published: 2017
Journal Articles

Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study

Michele Cavo, MD, Roman Hájek, MD, Lucia Pantani, MD, Meral Beksac, MD, Stefania Oliva, MD, Luca Dozza, Hans Erik Johnsen, MD Professor, Maria Teresa Petrucci, MD, Ulf-Henrik Mellqvist, MD, Concetta Conticello, MD, Christoph Driessen, MD, Giulia Marzocchi, BSc, Meletios A. Dimopoulos, Sonja Zweegman, MD PhD, Ka Lung Wu, MD, Barbara Gamberi, MD, Claudia Crippa, MD, Bronno van der Holt, Massimo Offidani, MD, Ruth Wester, Iolanda Donatella Vincelli, MD, Rossella Troia, Petra Cornelisse, Mario Boccadoro, MD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 397.
https://doi.org/10.1182/blood.V130.Suppl_1.397.397
Published: 2017
Journal Articles

Bortezomib-Based Therapy Overcomes the Adverse Impact of Renal Impairment in Transplant Eligible Patients: An Analysis of the Prospective Randomized EMN02/HO95 Study

Meletios A. Dimopoulos, Efstathios Kastritis, Roman Hajek, Luca Dozza, Meral Beksac, MD, Alessandra Larocca, Hans Erik Johnsen, MD Professor, Ulf-Henrik Mellqvist, MD, Anders Waage, MD PhD, Sonja Zweegman, MD PhD, Heinz Ludwig, MD, Lucia Pantani, MD, Andrew Spencer, MD, Anna Pascarella, Marina Martello, Susana Carvalho, Hlif Steingrimsdottir, MD, Claudia Cellini, MD, Petra Cornelisse, Rossella Troia, Patrizia Tosi, MD, Bronno van der Holt, Mario Boccadoro, Pieter Sonneveld, MDPhD, Michele Cavo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4545.
https://doi.org/10.1182/blood.V130.Suppl_1.4545.4545
Published: 2017
Journal Articles

Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Michele Cavo, Meral Beksac, MD, Meletios A Dimopoulos, Lucia Pantani, Francesca Gay, MD, Roman Hájek, Nicoletta Testoni, Ulf-Henrik Mellqvist, Francesca Patriarca, Vittorio Montefusco, MD, Monica Galli, Hans Erik Johnsen, MDDMSc, Heinz Ludwig, Sonja Zweegman, Ruth Wester, Ka Lung Wu, Christoph Driessen, Rossella Troia, Petra Cornelisse, Bronno van der Holt, PhD, Antonio Palumbo, MD, Pieter Sonneveld
Journal: Blood
Blood (2016) 128 (22): 673.
https://doi.org/10.1182/blood.V128.22.673.673
Published: 2016
Journal Articles

Consolidation Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Pieter Sonneveld, MDPhD, Meral Beksac, Professor, Bronno van der Holt, PhD, Meletios A. Dimopoulos, Angelo Michele Carella, Heinz Ludwig, Christoph Driessen, MD PhD, Ruth Wester, Roman Hajek, Sandra Croockewit, Rossella Troia, Francesca Gay, MD, Anna Maria Cafro, Luca De Rosa, G Fioritoni, MD, Ulf-Henrik Mellqvist, Hans Erik Johnsen, MDDMSc, Sonja Zweegman, MD PhD, Ka Lung Wu, Joana Parreira, MD, Fredrik H. Schjesvold, MD, James D'Rozario, Antonio Palumbo, MD, Michele Cavo
Journal: Blood
Blood (2016) 128 (22): 242.
https://doi.org/10.1182/blood.V128.22.242.242
Published: 2016
Journal Articles

Upfront Single Versus Double Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Michele Cavo, Maria Teresa Petrucci, Francesco Di Raimondo, MD, Elena Zamagni, Barbara Gamberi, MD, Claudia Crippa, Giulia Marzocchi, Mariella Grasso, MD, Stelvio Ballanti, MD, Donatella Iolanda Vincelli, MD, Paola Tacchetti, Massimo Offidani, Gianpietro Semenzato, Anna Marina Liberati, MD, Anna Pascarella, Giulia Benevolo, MD, Rossella Troia, Angelo D. Palmas, Nicola Cantore, Rita Rizzi, Fortunato Morabito, Mario Boccadoro, MD, Pieter Sonneveld
Journal: Blood
Blood (2016) 128 (22): 991.
https://doi.org/10.1182/blood.V128.22.991.991
Published: 2016